Pharmafile Logo

UCL

- PMLiVE

Brexit: can pharma ‘take back control’ of the narrative?

Four Public Affairs managing director Sarah Jones talks to PME about the risks of Brexit - and how the sector musn't let the long-term issues become obscured

- PMLiVE

Warning ‘at red’ on no deal Brexit medicines chaos

Report says it's already too late to prepare for a no deal scenario

- PMLiVE

Budget 2018: UK life sciences sector delivers its verdict

UK Chancellor Philip Hammond delivered a budget that was broadly pro-business but contained mixed news for the life sciences industry, according to two industry bodies.The headline news of an additional...

- PMLiVE

UK science could be ‘crippled’ by a hard Brexit

Francis Crick Institute scientists more likely to leave UK post-Brexit

- PMLiVE

AZ says UK investments on hold until there is Brexit ‘clarity’

Tomorrow's EU summit could be make-or-break for Brexit deal

- PMLiVE

UK pharma leader warns on ‘untenable’ Brexit deal

Draft agreement is a major step back for UK

- PMLiVE

The case for a second Brexit referendum: “We need the informed consent of the people”

Dr Phillip Lee MP is fighting to keep the UK in the EMA network - and for a second referendum

- PMLiVE

Brexit migration measures threaten UK clinical research

Calls for less restrictive working visa requirements

- PMLiVE

Clinical trial ‘High Throughput Centres’ could help UK compete post-Brexit

Proposals come as EU plans major upgrade in trials regulation

The dark side of direct-to-consumer genetic tests

Direct-to-consumer testing is an affordable way to better understand your DNA, but is this a leap forward in innovation or another layer clouding an already complex market? From anxious patients...

Blue Latitude Health

- PMLiVE

AstraZeneca chief on Brexit: “It’s going to be really painful”

Soriot also claims to be lowest paid CEO in sector

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links